Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Boehringer Ingelheim has signed with Zhangjiang Biotech & Pharmaceutical Base Development Company in Pudong, Shanghai a strategic alliance agreement and contract to build a cGMP biopharmaceuticals facility. The new site will provide full range of ...
read more
On June 18, 2013 a Technical Conference on Sterile Manufacturing, organized by ISPE Spain, will be held at Telstar’s Corporate Headquarters and Life Sciences facility in Terrassa (Barcelona). This conference is focused on the latest developments in ...
read more
Following the success of one of its key client partnered products, Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Together with the recent completion of a new non-GMP drug development facility at ...
read more
Catalent Pharma Solutions, a leading global drug delivery technology and advanced supply solutions company, has announced a major expansion of its controlled release drug manufacturing facility in Winchester, Kentucky. The company is to invest nearly...
read more
11 June 2013 - Recipharm AB is pleased to announce that it is working with Vectura Group plc to provide access to its licence for the regulatory dossier of Asmasal® for the Chinese regulatory authorities as part of the Chinese market approval process...
read more
Ash Stevens, Inc. (ASI), a leading provider of global contract pharmaceutical drug substance development and API (Active Pharmaceutical Ingredient) manufacturing services, announces the U.S. Food and Drug Administration (FDA) has approved ASI's ...
read more
AMRI announced today that Susan Collins has been promoted to Director of Business Development for North American Discovery Services, reporting to Christopher Conway, Vice President, Business Development. In this new role, Ms. Collins is responsible ...
read more
As part of OsoBio’s quality control department, the microbiology and chemistry laboratories that Larese now directs are responsible for environmental monitoring, analytical method development, and testing all incoming raw materials, components, and ...
read more
Work to be showcased at the 2013 Controlled Release Society annual meeting shows that Hyasis®, the Bacillus-derived Hyaluronic acid from Novozymes Biopharma, helps formulation scientists meet emerging challenges in drug development with controlled ...
read more
Aesica, the global contract development and manufacturing organisation (CDMO), has appointed Sven Thomas and David Ross as business development managers. Their appointment is the next phase in the company’s international drive to increase sales from ...
read more
-- 100 Contract Research and Contract Manufacturing Organizations will be exhibiting at this year's September 17-19, 2013 Pharma ChemOutsourcing Show at the Jersey Shore reported Apaporis LLC, the organizer. The companies offer a wide range of ...
read more
OsoBio has named Lindsey Pruitt manager of new business development for its East Coast market.
read more
Alkermes plc today will present an overview of its proprietary pipeline portfolio at its Research and Development (R&D) Day meeting for analysts and investors. For the first time, the company will discuss three new drug candidates including: a ...
read more
As previously disclosed, Albany Molecular Research, Inc. received a warning letter, dated August 17, 2010, from the U.S. Food and Drug Administration (FDA) in connection with the FDA’s inspection of the Company’s pharmaceutical manufacturing ...
read more
With the global market for asthma and COPD drugs set to reach $47bn in 2017, inhalation drug delivery systems are gathering momentum as pharmaceutical companies develop faster acting and more effective orally inhaled products. It is crucial for ...
read more